SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-136617
Filing Date
2021-11-10
Accepted
2021-11-10 07:30:39
Documents
47
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132367d1_8k.htm   iXBRL 8-K 29326
2 EXHIBIT 99.1 tm2132367d1_ex99-1.htm EX-99.1 157890
3 EXHIBIT 99.2 tm2132367d1_ex99-2.htm EX-99.2 46985
7 GRAPHIC tm2132367d1_ex99-2img001.jpg GRAPHIC 1390905
8 GRAPHIC tm2132367d1_ex99-2img002.jpg GRAPHIC 96684
9 GRAPHIC tm2132367d1_ex99-2img003.jpg GRAPHIC 79128
10 GRAPHIC tm2132367d1_ex99-2img004.jpg GRAPHIC 41390
11 GRAPHIC tm2132367d1_ex99-2img005.jpg GRAPHIC 50183
12 GRAPHIC tm2132367d1_ex99-2img006.jpg GRAPHIC 1443233
13 GRAPHIC tm2132367d1_ex99-2img007.jpg GRAPHIC 52600
14 GRAPHIC tm2132367d1_ex99-2img008.jpg GRAPHIC 98142
15 GRAPHIC tm2132367d1_ex99-2img009.jpg GRAPHIC 257017
16 GRAPHIC tm2132367d1_ex99-2img010.jpg GRAPHIC 88456
17 GRAPHIC tm2132367d1_ex99-2img011.jpg GRAPHIC 81415
18 GRAPHIC tm2132367d1_ex99-2img012.jpg GRAPHIC 666617
19 GRAPHIC tm2132367d1_ex99-2img013.jpg GRAPHIC 64818
20 GRAPHIC tm2132367d1_ex99-2img014.jpg GRAPHIC 1433830
21 GRAPHIC tm2132367d1_ex99-2img015.jpg GRAPHIC 123880
22 GRAPHIC tm2132367d1_ex99-2img016.jpg GRAPHIC 196640
23 GRAPHIC tm2132367d1_ex99-2img017.jpg GRAPHIC 120713
24 GRAPHIC tm2132367d1_ex99-2img018.jpg GRAPHIC 101135
25 GRAPHIC tm2132367d1_ex99-2img019.jpg GRAPHIC 252682
26 GRAPHIC tm2132367d1_ex99-2img020.jpg GRAPHIC 304865
27 GRAPHIC tm2132367d1_ex99-2img021.jpg GRAPHIC 179267
28 GRAPHIC tm2132367d1_ex99-2img022.jpg GRAPHIC 95763
29 GRAPHIC tm2132367d1_ex99-2img023.jpg GRAPHIC 74314
30 GRAPHIC tm2132367d1_ex99-2img024.jpg GRAPHIC 652446
31 GRAPHIC tm2132367d1_ex99-2img025.jpg GRAPHIC 68173
32 GRAPHIC tm2132367d1_ex99-2img026.jpg GRAPHIC 80884
33 GRAPHIC tm2132367d1_ex99-2img027.jpg GRAPHIC 642318
34 GRAPHIC tm2132367d1_ex99-2img028.jpg GRAPHIC 163759
35 GRAPHIC tm2132367d1_ex99-2img029.jpg GRAPHIC 60696
36 GRAPHIC tm2132367d1_ex99-2img030.jpg GRAPHIC 164713
37 GRAPHIC tm2132367d1_ex99-2img031.jpg GRAPHIC 42940
38 GRAPHIC tm2132367d1_ex99-2img032.jpg GRAPHIC 149562
39 GRAPHIC tm2132367d1_ex99-1img001.jpg GRAPHIC 5658
  Complete submission text file 0001104659-21-136617.txt   13291796

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vyne-20211110.xsd EX-101.SCH 3216
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vyne-20211110_lab.xml EX-101.LAB 34594
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vyne-20211110_pre.xml EX-101.PRE 22731
40 EXTRACTED XBRL INSTANCE DOCUMENT tm2132367d1_8k_htm.xml XML 3712
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 211394406
SIC: 2834 Pharmaceutical Preparations